Tarsus Pharmaceuticals, Inc.

Shawn D Hickok

Douglas Michael Ackermann, Jr

Bobak Robert Azamian

Douglas Michael Ackermann

Joseph G Vehige

Disclosed herein are compositions which can be used in methods for treating or preventing ophthalmic and dermatologic conditions in a human subject, including ocular surface conditions such as blepharitis or rosacea. The compositions can be topically administered directly to an eye, eyelid, or eyelashes of the patient for targeted local activity.

Isoxazoline parasiticide formulations

Disclosed herein are methods for treating or preventing ophthalmic and dermatologic conditions in a patient, including ocular surface conditions such as blepharitis. The methods can include topically administering directly to an ocular surface of one or more eyes of a patient in need of treatment thereof an effective amount of an isoxazoline parasiticide, formamidine parasiticide, or other active ingredient, formulated into an ophthalmic composition, the ophthalmic composition further comprising a pharmaceutically acceptable vehicle. Compositions are also disclosed.

Isoxazoline parasiticide formulations and methods for treating blepharitis

Ophthalmic compositions for treating ocularusing lotilaner formulations

Methods for treating demodex blepharitis using lotilaner formulations

Methods for treating ocularusing lotilaner formulations

Methods for treating ocular demodex using isoxazoline parasiticide formulations

Growing community of inventors

Aliso Viejo, CA, United States of America

Shawn D Hickok